autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine
Term · Oncology and biomedicine · MLC-T-ONC-011614
A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-011614 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011614",
"term": "autologous EBV-transformed B lymphoblastoid-tumor fusion cell vaccine",
"field": "Oncology and biomedicine",
"definition": "A cell-based vaccine composed of autologous tumor cells fused with Epstein-Barr virus-transformed B-lymphoblastoid cells. Upon administration, this vaccine may stimulate a cytotoxic T cell response against tumor cells, resulting in tumor cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-ebv-transformed-b-lymphoblastoid-tumor-fusion-cell-vaccine/"
}
Record 2,948 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.